AUTL

Autolus Therapeutics
AUTL

Overview Fund Activity

66 hedge funds and large institutions have $229M invested in Autolus Therapeutics in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 26 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
-7
Holders Change %
-9.59%
% of All Funds
1.04%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
18
Reduced
26
Closed
15
Calls
$248K
Puts
$10K
Net Calls
+$238K
Net Calls Change
-$289K

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$14.6M
2
LCP
2
LGT Capital Partners
Switzerland
$2.09M
3
DCM
3
DAFNA Capital Management
California
$2.07M
4
DTC
4
Deep Track Capital
Connecticut
$1.6M
5
NCM
5
Nantahala Capital Management
Connecticut
$18.1M

Top Sellers

1
FM
1
Frazier Management
Washington
$0
2
Capital World Investors
2
Capital World Investors
California
$4.42M
3
SG Americas Securities
3
SG Americas Securities
New York
$0
4
IC
4
Ikarian Capital
Texas
$1.55M
5
SM
5
Sabby Management
Florida
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
TCWM
76
Total Clarity Wealth Management
Illinois
– -$6K -1,200 Closed
CFGS
77
Concourse Financial Group Securities
Alabama
– -$5K -1,000 Closed
Northwestern Mutual Wealth Management
78
Northwestern Mutual Wealth Management
Wisconsin
– -$1K -200 Closed
1 2 3
4